MedPath
FDA Approval

Morphine Sulfate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
April 21, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Morphine(20 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Quality Care Products LLC

Quality Care Products LLC

831276758

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Morphine Sulfate

Product Details

NDC Product Code
55700-349
Application Number
ANDA202104
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
February 12, 2018
MorphineActive
Code: X3P646A2J0Class: ACTIBQuantity: 20 mg in 1 1
hypromellosesInactive
Code: 3NXW29V3WOClass: IACT
cellulose, microcrystallineInactive
Code: OP1R32D61UClass: IACT
ethylcellulosesInactive
Code: 7Z8S9VYZ4BClass: IACT
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE AInactive
Code: NX76LV5T8JClass: IACT
POLYETHYLENE GLYCOL 4000Inactive
Code: 4R4HFI6D95Class: IACT
diethyl phthalateInactive
Code: UF064M00AFClass: IACT
talcInactive
Code: 7SEV7J4R1UClass: IACT
gelatinInactive
Code: 2G86QN327LClass: IACT
titanium dioxideInactive
Code: 15FIX9V2JPClass: IACT
D&C Yellow No. 10Inactive
Code: 35SW5USQ3GClass: IACT
© Copyright 2025. All Rights Reserved by MedPath